NCT00376623 - Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 25, 2006

Primary Completion Date

April 1, 2008

Study Completion Date

April 1, 2008

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG

BI 2536

Intravenous Infusion

Trial Locations (7)

1216.9.49002 Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

1216.9.49007 Boehringer Ingelheim Investigational Site, Gauting

1216.9.49008 Boehringer Ingelheim Investigational Site, Großhansdorf

1216.9.49001 Boehringer Ingelheim Investigational Site, Heidelberg

1216.9.49004 Boehringer Ingelheim Investigational Site, Mainz

1216.9.49005 Boehringer Ingelheim Investigational Site, Mainz

1216.9.49003 Boehringer Ingelheim Investigational Site, Wiesbaden